Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,616 | 237 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,252 | 62 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $429.68 | 22 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $386.70 | 18 | $0 (2021) |
| Shire North American Group Inc | $314.49 | 17 | $0 (2019) |
| Amgen Inc. | $308.44 | 5 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $269.02 | 12 | $0 (2023) |
| Allergan, Inc. | $234.69 | 12 | $0 (2022) |
| Harrow Eye, LLC | $219.90 | 9 | $0 (2024) |
| Oyster Point Pharma, Inc. | $214.15 | 10 | $0 (2024) |
| Alcon Vision LLC | $205.21 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,371 | 47 | Amgen Inc. ($308.44) |
| 2023 | $932.69 | 38 | Horizon Therapeutics plc ($201.65) |
| 2022 | $569.57 | 29 | Novartis Pharmaceuticals Corporation ($189.96) |
| 2021 | $424.31 | 20 | Aerie Pharmaceuticals, Inc. ($89.27) |
| 2020 | $532.49 | 21 | NEW WORLD MEDICAL,INC. ($119.03) |
| 2019 | $700.95 | 28 | Novartis Pharmaceuticals Corporation ($264.06) |
| 2018 | $687.24 | 31 | Novartis Pharmaceuticals Corporation ($341.04) |
| 2017 | $396.98 | 23 | Novartis Pharmaceuticals Corporation ($134.37) |
All Payment Transactions
237 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: EYE CARE | ||||||
| 12/09/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: OPTOMETRY | ||||||
| 11/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $124.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/15/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/28/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: OPTOMETRY | ||||||
| 10/21/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/14/2024 | Harrow Eye, LLC | ILEVRO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: OPTOMETRY | ||||||
| 10/07/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: OPTOMETRY | ||||||
| 09/26/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Dry eyes | ||||||
| 09/16/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: OPTOMETRY | ||||||
| 08/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/12/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: OPTOMETRY | ||||||
| 08/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $120.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/25/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: OPTOMETRY | ||||||
| 07/22/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Ophthalmology | ||||||
| 07/10/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Ophthalmology | ||||||
| 07/01/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 289 | 344 | $68,355 | $17,570 |
| 2022 | 11 | 519 | 606 | $122,695 | $31,129 |
| 2021 | 12 | 593 | 668 | $127,475 | $37,922 |
| 2020 | 15 | 993 | 1,133 | $194,865 | $70,253 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 36 | 51 | $8,940 | $3,654 | 40.9% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 21 | 47 | $5,330 | $3,521 | 66.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 32 | 33 | $6,790 | $2,793 | 41.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 47 | 52 | $13,860 | $2,547 | 18.4% |
| 92250 | Photography of the retina | Office | 2023 | 50 | 55 | $9,910 | $1,558 | 15.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 16 | 16 | $2,750 | $1,457 | 53.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 27 | 29 | $8,300 | $789.21 | 9.5% |
| 92134 | Imaging of retina | Office | 2023 | 23 | 24 | $6,150 | $704.03 | 11.4% |
| 92285 | Photography of content of eyes | Office | 2023 | 16 | 16 | $2,175 | $304.02 | 14.0% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 21 | 21 | $4,150 | $243.00 | 5.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 73 | 103 | $17,770 | $7,423 | 41.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 61 | 63 | $13,280 | $5,356 | 40.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 79 | 94 | $25,670 | $4,886 | 19.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 27 | 57 | $6,470 | $4,240 | 65.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 35 | 35 | $6,410 | $2,878 | 44.9% |
| 92250 | Photography of the retina | Office | 2022 | 87 | 91 | $16,520 | $2,519 | 15.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 45 | 48 | $13,650 | $1,310 | 9.6% |
| 92134 | Imaging of retina | Office | 2022 | 36 | 37 | $9,750 | $1,290 | 13.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 41 | 41 | $8,100 | $512.17 | 6.3% |
| 92285 | Photography of content of eyes | Office | 2022 | 23 | 24 | $3,225 | $433.76 | 13.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 12 | 13 | $1,850 | $282.94 | 15.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 60 | 102 | $16,910 | $8,028 | 47.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 73 | 74 | $15,660 | $7,493 | 47.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 95 | 103 | $24,680 | $6,068 | 24.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 53 | 53 | $8,790 | $5,477 | 62.3% |
About Dr. Viktoriya Gutkevich, O.D
Dr. Viktoriya Gutkevich, O.D is a Optometrist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831171743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Viktoriya Gutkevich, O.D has received a total of $5,616 in payments from pharmaceutical and medical device companies, with $1,371 received in 2024. These payments were reported across 237 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,616).
As a Medicare-enrolled provider, Gutkevich has provided services to 2,394 Medicare beneficiaries, totaling 2,751 services with total Medicare billing of $156,875. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Brooklyn, NY
- Active Since 11/16/2005
- Last Updated 11/22/2013
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1831171743
Products in Payments
- XIIDRA (Drug) $1,089
- VYZULTA (Drug) $553.96
- TEPEZZA (Biological) $308.44
- TRAVATAN Z (Drug) $280.34
- TYRVAYA (Drug) $214.15
- TEPEZZA (Drug) $201.65
- VEVYE (Drug) $197.68
- Ahmed Glaucoma Valve (Device) $162.14
- PROLENSA (Drug) $151.27
- PAZEO (Drug) $137.74
- LUMIGAN (Drug) $133.23
- INVELTYS (Drug) $129.71
- Acuvue (Device) $124.36
- Rocklatan (Drug) $120.94
- PROKERA (Device) $119.13
- DURYSTA (Drug) $112.82
- EYLEA HD (Biological) $94.84
- XDEMVY (Drug) $90.55
- CEQUA (Drug) $90.34
- rocklatan (Drug) $89.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Brooklyn
Dr. Justin Bazan, Od, OD
Optometrist — Payments: $511,024
Katherine Mastrota, Od, OD
Optometrist — Payments: $56,972
Daniel Epshtein, O.d, O.D
Optometrist — Payments: $41,377
Dr. Marcien Pierre, Od, OD
Optometrist — Payments: $7,455
Dr. Sally Chetrit, O.d, O.D
Optometrist — Payments: $6,327
Dr. Natalya Rooney, Od, OD
Optometrist — Payments: $6,200